J&J lupus treatment cut disease activity for 52 weeks in Phase 2 trial

J&J lupus treatment cut disease activity for 52 weeks in Phase 2 trial  Stock Titan

Summary aggregated from Stock Titan's public RSS feed. The full reporting belongs to Stock Titan — please read it on their site.